These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 35255603

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies.
    Petrone A, Battelino T, Krzisnik C, Bugawan T, Erlich H, Di Mario U, Pozzilli P, Buzzetti R.
    Tissue Antigens; 2002 Sep; 60(3):244-53. PubMed ID: 12445307
    [Abstract] [Full Text] [Related]

  • 27. Association of a polymorphism in the betacellulin gene with type 1 diabetes mellitus in two populations.
    Silver KD, Magnuson VL, Tolea M, Wang J, Hagopian WA, Mitchell BD.
    J Mol Med (Berl); 2006 Jul; 84(7):616-23. PubMed ID: 16683131
    [Abstract] [Full Text] [Related]

  • 28. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
    Godwin JL, Jaggi S, Sirisena I, Sharda P, Rao AD, Mehra R, Veloski C.
    J Immunother Cancer; 2017 Jul; 5():40. PubMed ID: 28515940
    [Abstract] [Full Text] [Related]

  • 29. HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency.
    Ono M, Fukuda I, Nagao M, Tomiyama K, Okazaki-Hada M, Shuto Y, Kobayashi S, Yamaguchi Y, Nagamine T, Nakajima Y, Inagaki-Tanimura K, Sugihara H.
    Pituitary; 2022 Aug; 25(4):615-621. PubMed ID: 35653047
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
    Chu X, Zhao J, Zhou J, Zhou F, Jiang T, Jiang S, Sun X, You X, Wu F, Ren S, Zhou C, Su C.
    Lung Cancer; 2020 Dec; 150():76-82. PubMed ID: 33080551
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Association of HLA class II alleles and CTLA-4 polymorphism with type 1 diabetes.
    Ei Wafai RJ, Chmaisse HN, Makki RF, Fakhoury H.
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):273-81. PubMed ID: 21422625
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Trends in the frequency of HLA DR-DQ haplotypes among children and adolescents with type 1 diabetes mellitus in the Southeast Region of Turkey.
    Keskin M, Aygün A, Pehlivan S, Keskin Ö, Kor Y, Balat A, Coşkun Y.
    J Clin Res Pediatr Endocrinol; 2012 Dec; 4(4):189-92. PubMed ID: 23261861
    [Abstract] [Full Text] [Related]

  • 36. Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study).
    Buzzetti R, Galgani A, Petrone A, Del Buono ML, Erlich HA, Bugawan TL, Lorini R, Meschi F, Multari G, Pozzilli P, Locatelli M, Bottazzo G, Di Mario U.
    Diabetes Metab Res Rev; 2004 Dec; 20(2):137-43. PubMed ID: 15037989
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E, Vinson M, Hayes E, Hsu YM, Houtchens K, Erlich H, Klitz W, Hsia Y, Hollenbach J.
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [Abstract] [Full Text] [Related]

  • 40. Predictors of the Onset of Type 1 Diabetes Obtained from Real-World Data Analysis in Cancer Patients Treated with Immune Checkpoint Inhibitors.
    Takada S, Hirokazu H, Yamagishi K, Hideki S, Masayuki E.
    Asian Pac J Cancer Prev; 2020 Jun 01; 21(6):1697-1699. PubMed ID: 32592366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.